Pharmaceutical products (Франция - Тендер #47436805)

1. Section I
   1. Name and addresses
      centre Hospitalier de Nevers
      1 avenue Patrick Guillot Bp649
      Nevers Cedex
      58033
      France
      E-mail: Chan.cellule.marches@ght58.fr
      
   2. Joint procurement
      
   3. Communication
      The procurement documents are available for unrestricted and full direct access, free of charge, at
      https://marches.ternum-bfc.fr/?page=Entreprise.EntrepriseAdvancedSearch&AllCons&id=661209&orgAcronyme=x1j
      Additional information can be obtained from the abovementioned addresselectronically via: https://marches.ternum-bfc.fr/?page=Entreprise.EntrepriseAdvancedSearch&AllCons&id=661209&orgAcronyme=x1j
      
      
   4. Type of the contracting authority:
      Body governed by public law
      
   5. Main activity:
      Health
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         gauloys - fourniture de produits pharmaceutiques: Médicaments - 83 lots

         Reference number: 2023-94
         
      2. Main CPV code:
         33600000
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         gauloys - fourniture de produits pharmaceutiques: Médicaments - 83 lots

      5. Estimated total value:
         
         
      6. Information about lots:
         all lots
   2. Description
      1. Title:
         

         charbon active - forme orale seche

         Lot No: 1
         
      2. Additional CPV code(s):
         33600000
         
      3. Place of performance:
         
      4. Description of the procurement:
         

         charbon active - forme orale seche

      5. Award criteria:
         Price is not the only award criterion and all criteria are stated only in the procurement documents
      6. Estimated value:
         
         
      7. Duration of the contract, framework agreement or dynamic purchasing system:
         Duration in months: 12
         This contract is subject to renewal: yes
         Description of renewals:

         l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      8. Information about the limits on the number of candidates to be invited:
         
      9. Information about variants:
         Variants will be accepted: no
         
      10. Information about options:
          Options: no
      11. Information about electronic catalogues:
          
          
      12. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      13. Additional information:
          
      14. Title:
          

          glycerine - forme rectale - suppositoire

          Lot No: 2
          
      15. Additional CPV code(s):
          33600000
          
      16. Place of performance:
          
      17. Description of the procurement:
          

          glycerine - forme rectale - suppositoire

      18. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      19. Estimated value:
          
          
      20. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      21. Information about the limits on the number of candidates to be invited:
          
      22. Information about variants:
          Variants will be accepted: no
          
      23. Information about options:
          Options: no
      24. Information about electronic catalogues:
          
          
      25. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      26. Additional information:
          
      27. Title:
          

          granisetron - solution injectable

          Lot No: 3
          
      28. Additional CPV code(s):
          33600000
          
      29. Place of performance:
          
      30. Description of the procurement:
          

          granisetron - solution injectable

      31. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      32. Estimated value:
          
          
      33. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      34. Information about the limits on the number of candidates to be invited:
          
      35. Information about variants:
          Variants will be accepted: no
          
      36. Information about options:
          Options: no
      37. Information about electronic catalogues:
          
          
      38. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      39. Additional information:
          
      40. Title:
          

          metopimazine - forme orale seche lyophilisat ou orodispersible

          Lot No: 4
          
      41. Additional CPV code(s):
          33600000
          
      42. Place of performance:
          
      43. Description of the procurement:
          

          metopimazine - forme orale seche lyophilisat ou orodispersible

      44. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      45. Estimated value:
          
          
      46. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      47. Information about the limits on the number of candidates to be invited:
          
      48. Information about variants:
          Variants will be accepted: no
          
      49. Information about options:
          Options: no
      50. Information about electronic catalogues:
          
          
      51. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      52. Additional information:
          
      53. Title:
          

          ondansetron - forme orale seche

          Lot No: 5
          
      54. Additional CPV code(s):
          33600000
          
      55. Place of performance:
          
      56. Description of the procurement:
          

          ondansetron - forme orale seche

      57. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      58. Estimated value:
          
          
      59. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      60. Information about the limits on the number of candidates to be invited:
          
      61. Information about variants:
          Variants will be accepted: no
          
      62. Information about options:
          Options: no
      63. Information about electronic catalogues:
          
          
      64. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      65. Additional information:
          
      66. Title:
          

          sapropterine - poudre ou comprime pour solution buvable

          Lot No: 6
          
      67. Additional CPV code(s):
          33600000
          
      68. Place of performance:
          
      69. Description of the procurement:
          

          sapropterine - poudre ou comprime pour solution buvable

      70. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      71. Estimated value:
          
          
      72. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      73. Information about the limits on the number of candidates to be invited:
          
      74. Information about variants:
          Variants will be accepted: no
          
      75. Information about options:
          Options: no
      76. Information about electronic catalogues:
          
          
      77. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      78. Additional information:
          
      79. Title:
          

          saxagliptine - forme orale seche

          Lot No: 7
          
      80. Additional CPV code(s):
          33600000
          
      81. Place of performance:
          
      82. Description of the procurement:
          

          saxagliptine - forme orale seche

      83. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      84. Estimated value:
          
          
      85. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      86. Information about the limits on the number of candidates to be invited:
          
      87. Information about variants:
          Variants will be accepted: no
          
      88. Information about options:
          Options: no
      89. Information about electronic catalogues:
          
          
      90. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      91. Additional information:
          
      92. Title:
          

          sitagliptine + metformine - forme orale seche

          Lot No: 8
          
      93. Additional CPV code(s):
          33600000
          
      94. Place of performance:
          
      95. Description of the procurement:
          

          sitagliptine + metformine - forme orale seche

      96. Award criteria:
          Price is not the only award criterion and all criteria are stated only in the procurement documents
      97. Estimated value:
          
          
      98. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: yes
          Description of renewals:

          l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      99. Information about the limits on the number of candidates to be invited:
          
      100. Information about variants:
           Variants will be accepted: no
           
      101. Information about options:
           Options: no
      102. Information about electronic catalogues:
           
           
      103. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      104. Additional information:
           
      105. Title:
           

           sorbitol - forme orale seche

           Lot No: 9
           
      106. Additional CPV code(s):
           33600000
           
      107. Place of performance:
           
      108. Description of the procurement:
           

           sorbitol - forme orale seche

      109. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      110. Estimated value:
           
           
      111. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      112. Information about the limits on the number of candidates to be invited:
           
      113. Information about variants:
           Variants will be accepted: no
           
      114. Information about options:
           Options: no
      115. Information about electronic catalogues:
           
           
      116. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      117. Additional information:
           
      118. Title:
           

           vildagliptine + metformine - forme orale seche

           Lot No: 10
           
      119. Additional CPV code(s):
           33600000
           
      120. Place of performance:
           
      121. Description of the procurement:
           

           vildagliptine + metformine - forme orale seche

      122. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      123. Estimated value:
           
           
      124. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      125. Information about the limits on the number of candidates to be invited:
           
      126. Information about variants:
           Variants will be accepted: no
           
      127. Information about options:
           Options: no
      128. Information about electronic catalogues:
           
           
      129. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      130. Additional information:
           
      131. Title:
           

           vitamine b1 - forme orale seche

           Lot No: 11
           
      132. Additional CPV code(s):
           33600000
           
      133. Place of performance:
           
      134. Description of the procurement:
           

           vitamine b1 - forme orale seche

      135. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      136. Estimated value:
           
           
      137. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      138. Information about the limits on the number of candidates to be invited:
           
      139. Information about variants:
           Variants will be accepted: no
           
      140. Information about options:
           Options: no
      141. Information about electronic catalogues:
           
           
      142. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      143. Additional information:
           
      144. Title:
           

           vitamine b6 - forme orale seche

           Lot No: 12
           
      145. Additional CPV code(s):
           33600000
           
      146. Place of performance:
           
      147. Description of the procurement:
           

           vitamine b6 - forme orale seche

      148. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      149. Estimated value:
           
           
      150. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      151. Information about the limits on the number of candidates to be invited:
           
      152. Information about variants:
           Variants will be accepted: no
           
      153. Information about options:
           Options: no
      154. Information about electronic catalogues:
           
           
      155. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      156. Additional information:
           
      157. Title:
           

           dabigatran - forme orale seche

           Lot No: 13
           
      158. Additional CPV code(s):
           33600000
           
      159. Place of performance:
           
      160. Description of the procurement:
           

           dabigatran - forme orale seche

      161. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      162. Estimated value:
           
           
      163. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      164. Information about the limits on the number of candidates to be invited:
           
      165. Information about variants:
           Variants will be accepted: no
           
      166. Information about options:
           Options: no
      167. Information about electronic catalogues:
           
           
      168. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      169. Additional information:
           
      170. Title:
           

           fer - solution ou dispersion injectable

           Lot No: 14
           
      171. Additional CPV code(s):
           33600000
           
      172. Place of performance:
           
      173. Description of the procurement:
           

           fer - solution ou dispersion injectable

      174. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      175. Estimated value:
           
           
      176. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      177. Information about the limits on the number of candidates to be invited:
           
      178. Information about variants:
           Variants will be accepted: no
           
      179. Information about options:
           Options: no
      180. Information about electronic catalogues:
           
           
      181. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      182. Additional information:
           
      183. Title:
           

           fondaparinux - solution injectable

           Lot No: 15
           
      184. Additional CPV code(s):
           33600000
           
      185. Place of performance:
           
      186. Description of the procurement:
           

           fondaparinux - solution injectable

      187. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      188. Estimated value:
           
           
      189. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      190. Information about the limits on the number of candidates to be invited:
           
      191. Information about variants:
           Variants will be accepted: no
           
      192. Information about options:
           Options: no
      193. Information about electronic catalogues:
           
           
      194. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      195. Additional information:
           
      196. Title:
           

           icatibant - solution injectable

           Lot No: 16
           
      197. Additional CPV code(s):
           33600000
           
      198. Place of performance:
           
      199. Description of the procurement:
           

           icatibant - solution injectable

      200. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      201. Estimated value:
           
           
      202. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      203. Information about the limits on the number of candidates to be invited:
           
      204. Information about variants:
           Variants will be accepted: no
           
      205. Information about options:
           Options: no
      206. Information about electronic catalogues:
           
           
      207. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      208. Additional information:
           
      209. Title:
           

           iloprost - solution injectable

           Lot No: 17
           
      210. Additional CPV code(s):
           33600000
           
      211. Place of performance:
           
      212. Description of the procurement:
           

           iloprost - solution injectable

      213. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      214. Estimated value:
           
           
      215. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      216. Information about the limits on the number of candidates to be invited:
           
      217. Information about variants:
           Variants will be accepted: no
           
      218. Information about options:
           Options: no
      219. Information about electronic catalogues:
           
           
      220. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      221. Additional information:
           
      222. Title:
           

           rivaroxaban - forme orale seche

           Lot No: 18
           
      223. Additional CPV code(s):
           33600000
           
      224. Place of performance:
           
      225. Description of the procurement:
           

           rivaroxaban - forme orale seche

      226. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      227. Estimated value:
           
           
      228. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      229. Information about the limits on the number of candidates to be invited:
           
      230. Information about variants:
           Variants will be accepted: no
           
      231. Information about options:
           Options: no
      232. Information about electronic catalogues:
           
           
      233. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      234. Additional information:
           
      235. Title:
           

           ticagrelor - forme orale seche

           Lot No: 19
           
      236. Additional CPV code(s):
           33600000
           
      237. Place of performance:
           
      238. Description of the procurement:
           

           ticagrelor - forme orale seche

      239. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      240. Estimated value:
           
           
      241. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      242. Information about the limits on the number of candidates to be invited:
           
      243. Information about variants:
           Variants will be accepted: no
           
      244. Information about options:
           Options: no
      245. Information about electronic catalogues:
           
           
      246. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      247. Additional information:
           
      248. Title:
           

           vitamine b12 - solution injectable et buvable

           Lot No: 20
           
      249. Additional CPV code(s):
           33600000
           
      250. Place of performance:
           
      251. Description of the procurement:
           

           vitamine b12 - solution injectable et buvable

      252. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      253. Estimated value:
           
           
      254. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      255. Information about the limits on the number of candidates to be invited:
           
      256. Information about variants:
           Variants will be accepted: no
           
      257. Information about options:
           Options: no
      258. Information about electronic catalogues:
           
           
      259. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      260. Additional information:
           
      261. Title:
           

           celiprolol - forme orale seche

           Lot No: 21
           
      262. Additional CPV code(s):
           33600000
           
      263. Place of performance:
           
      264. Description of the procurement:
           

           celiprolol - forme orale seche

      265. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      266. Estimated value:
           
           
      267. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      268. Information about the limits on the number of candidates to be invited:
           
      269. Information about variants:
           Variants will be accepted: no
           
      270. Information about options:
           Options: no
      271. Information about electronic catalogues:
           
           
      272. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      273. Additional information:
           
      274. Title:
           

           isoprenaline - solution injectable

           Lot No: 22
           
      275. Additional CPV code(s):
           33600000
           
      276. Place of performance:
           
      277. Description of the procurement:
           

           isoprenaline - solution injectable

      278. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      279. Estimated value:
           
           
      280. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      281. Information about the limits on the number of candidates to be invited:
           
      282. Information about variants:
           Variants will be accepted: no
           
      283. Information about options:
           Options: no
      284. Information about electronic catalogues:
           
           
      285. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      286. Additional information:
           
      287. Title:
           

           lauromacrogol 400 - solution injectable

           Lot No: 23
           
      288. Additional CPV code(s):
           33600000
           
      289. Place of performance:
           
      290. Description of the procurement:
           

           lauromacrogol 400 - solution injectable

      291. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      292. Estimated value:
           
           
      293. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      294. Information about the limits on the number of candidates to be invited:
           
      295. Information about variants:
           Variants will be accepted: no
           
      296. Information about options:
           Options: no
      297. Information about electronic catalogues:
           
           
      298. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      299. Additional information:
           
      300. Title:
           

           levosimendan - solution injectable

           Lot No: 24
           
      301. Additional CPV code(s):
           33600000
           
      302. Place of performance:
           
      303. Description of the procurement:
           

           levosimendan - solution injectable

      304. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      305. Estimated value:
           
           
      306. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      307. Information about the limits on the number of candidates to be invited:
           
      308. Information about variants:
           Variants will be accepted: no
           
      309. Information about options:
           Options: no
      310. Information about electronic catalogues:
           
           
      311. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      312. Additional information:
           
      313. Title:
           

           molsidomine - forme orale seche

           Lot No: 25
           
      314. Additional CPV code(s):
           33600000
           
      315. Place of performance:
           
      316. Description of the procurement:
           

           molsidomine - forme orale seche

      317. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      318. Estimated value:
           
           
      319. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      320. Information about the limits on the number of candidates to be invited:
           
      321. Information about variants:
           Variants will be accepted: no
           
      322. Information about options:
           Options: no
      323. Information about electronic catalogues:
           
           
      324. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      325. Additional information:
           
      326. Title:
           

           urapidil - forme orale seche

           Lot No: 26
           
      327. Additional CPV code(s):
           33600000
           
      328. Place of performance:
           
      329. Description of the procurement:
           

           urapidil - forme orale seche

      330. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      331. Estimated value:
           
           
      332. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      333. Information about the limits on the number of candidates to be invited:
           
      334. Information about variants:
           Variants will be accepted: no
           
      335. Information about options:
           Options: no
      336. Information about electronic catalogues:
           
           
      337. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      338. Additional information:
           
      339. Title:
           

           calcipotriol + betamethasone - forme pour application cutanee

           Lot No: 27
           
      340. Additional CPV code(s):
           33600000
           
      341. Place of performance:
           
      342. Description of the procurement:
           

           calcipotriol + betamethasone - forme pour application cutanee

      343. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      344. Estimated value:
           
           
      345. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      346. Information about the limits on the number of candidates to be invited:
           
      347. Information about variants:
           Variants will be accepted: no
           
      348. Information about options:
           Options: no
      349. Information about electronic catalogues:
           
           
      350. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      351. Additional information:
           
      352. Title:
           

           chlorhexidine alcoolique 0,5% - incolore - solution pour application cutanee

           Lot No: 28
           
      353. Additional CPV code(s):
           33600000
           
      354. Place of performance:
           
      355. Description of the procurement:
           

           chlorhexidine alcoolique 0,5% - incolore - solution pour application cutanee

      356. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      357. Estimated value:
           
           
      358. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      359. Information about the limits on the number of candidates to be invited:
           
      360. Information about variants:
           Variants will be accepted: no
           
      361. Information about options:
           Options: no
      362. Information about electronic catalogues:
           
           
      363. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      364. Additional information:
           
      365. Title:
           

           chlorhexidine alcoolique 2% - incolore - solution pour application cutanee

           Lot No: 29
           
      366. Additional CPV code(s):
           33600000
           
      367. Place of performance:
           
      368. Description of the procurement:
           

           chlorhexidine alcoolique 2% - incolore - solution pour application cutanee

      369. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      370. Estimated value:
           
           
      371. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      372. Information about the limits on the number of candidates to be invited:
           
      373. Information about variants:
           Variants will be accepted: no
           
      374. Information about options:
           Options: no
      375. Information about electronic catalogues:
           
           
      376. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      377. Additional information:
           
      378. Title:
           

           chlorhexidine aqueuse 0,2% - incolore - solution pour application cutanee

           Lot No: 30
           
      379. Additional CPV code(s):
           33600000
           
      380. Place of performance:
           
      381. Description of the procurement:
           

           chlorhexidine aqueuse 0,2% - incolore - solution pour application cutanee

      382. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      383. Estimated value:
           
           
      384. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      385. Information about the limits on the number of candidates to be invited:
           
      386. Information about variants:
           Variants will be accepted: no
           
      387. Information about options:
           Options: no
      388. Information about electronic catalogues:
           
           
      389. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      390. Additional information:
           
      391. Title:
           

           ethinylestradiol + gestodene - forme orale seche

           Lot No: 31
           
      392. Additional CPV code(s):
           33600000
           
      393. Place of performance:
           
      394. Description of the procurement:
           

           ethinylestradiol + gestodene - forme orale seche

      395. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      396. Estimated value:
           
           
      397. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      398. Information about the limits on the number of candidates to be invited:
           
      399. Information about variants:
           Variants will be accepted: no
           
      400. Information about options:
           Options: no
      401. Information about electronic catalogues:
           
           
      402. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      403. Additional information:
           
      404. Title:
           

           nomegestrol - forme orale seche

           Lot No: 32
           
      405. Additional CPV code(s):
           33600000
           
      406. Place of performance:
           
      407. Description of the procurement:
           

           nomegestrol - forme orale seche

      408. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      409. Estimated value:
           
           
      410. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      411. Information about the limits on the number of candidates to be invited:
           
      412. Information about variants:
           Variants will be accepted: no
           
      413. Information about options:
           Options: no
      414. Information about electronic catalogues:
           
           
      415. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      416. Additional information:
           
      417. Title:
           

           lanreotide - solution injectable a liberation prolongee

           Lot No: 33
           
      418. Additional CPV code(s):
           33600000
           
      419. Place of performance:
           
      420. Description of the procurement:
           

           lanreotide - solution injectable a liberation prolongee

      421. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      422. Estimated value:
           
           
      423. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      424. Information about the limits on the number of candidates to be invited:
           
      425. Information about variants:
           Variants will be accepted: no
           
      426. Information about options:
           Options: no
      427. Information about electronic catalogues:
           
           
      428. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      429. Additional information:
           
      430. Title:
           

           octreotide - poudre pour suspension injectable a liberation prolongee

           Lot No: 34
           
      431. Additional CPV code(s):
           33600000
           
      432. Place of performance:
           
      433. Description of the procurement:
           

           octreotide - poudre pour suspension injectable a liberation prolongee

      434. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      435. Estimated value:
           
           
      436. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      437. Information about the limits on the number of candidates to be invited:
           
      438. Information about variants:
           Variants will be accepted: no
           
      439. Information about options:
           Options: no
      440. Information about electronic catalogues:
           
           
      441. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      442. Additional information:
           
      443. Title:
           

           dalbavancine - poudre pour solution injectable

           Lot No: 35
           
      444. Additional CPV code(s):
           33600000
           
      445. Place of performance:
           
      446. Description of the procurement:
           

           dalbavancine - poudre pour solution injectable

      447. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      448. Estimated value:
           
           
      449. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      450. Information about the limits on the number of candidates to be invited:
           
      451. Information about variants:
           Variants will be accepted: no
           
      452. Information about options:
           Options: no
      453. Information about electronic catalogues:
           
           
      454. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      455. Additional information:
           
      456. Title:
           

           fusidate de sodium - forme orale seche

           Lot No: 36
           
      457. Additional CPV code(s):
           33600000
           
      458. Place of performance:
           
      459. Description of the procurement:
           

           fusidate de sodium - forme orale seche

      460. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      461. Estimated value:
           
           
      462. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      463. Information about the limits on the number of candidates to be invited:
           
      464. Information about variants:
           Variants will be accepted: no
           
      465. Information about options:
           Options: no
      466. Information about electronic catalogues:
           
           
      467. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      468. Additional information:
           
      469. Title:
           

           lopinavir + ritonavir - forme orale seche

           Lot No: 37
           
      470. Additional CPV code(s):
           33600000
           
      471. Place of performance:
           
      472. Description of the procurement:
           

           lopinavir + ritonavir - forme orale seche

      473. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      474. Estimated value:
           
           
      475. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      476. Information about the limits on the number of candidates to be invited:
           
      477. Information about variants:
           Variants will be accepted: no
           
      478. Information about options:
           Options: no
      479. Information about electronic catalogues:
           
           
      480. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      481. Additional information:
           
      482. Title:
           

           posaconazole - suspension buvable

           Lot No: 38
           
      483. Additional CPV code(s):
           33600000
           
      484. Place of performance:
           
      485. Description of the procurement:
           

           posaconazole - suspension buvable

      486. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      487. Estimated value:
           
           
      488. Duration of the contract, framework agreement or dynamic purchasing system:
           Duration in months: 12
           This contract is subject to renewal: yes
           Description of renewals:

           l"Accord cadre est conclu pour une première période ferme de 12 mois à compter du 01/01/2024 (ou date de notification si celle-ci est postérieure), soit jusqu"au 31/12/2024. Au terme de cette période initiale, l"accord cadre sera reconductible tacitement 3 fois 12 mois jusqu"au 31/12/2027

      489. Information about the limits on the number of candidates to be invited:
           
      490. Information about variants:
           Variants will be accepted: no
           
      491. Information about options:
           Options: no
      492. Information about electronic catalogues:
           
           
      493. Information about European Union funds:
           The procurement is related to a project and/or programme financed by European Union funds: no
      494. Additional information:
           
      495. Title:
           

           vaccin fievre jaune - poudre et solvant pour suspension injectable

           Lot No: 39
           
      496. Additional CPV code(s):
           33600000
           
      497. Place of performance:
           
      498. Description of the procurement:
           

           vaccin fievre jaune - poudre et solvant pour suspension injectable

      499. Award criteria:
           Price is not the only award criterion and all criteria are stated only in the procurement documents
      500. Estimated value:
           
           
      501. Duration of the contract, framework agreement or dynamic purchasing

Источник закупки

Импорт - Экспорт по стране Франция